A Glutamine antagonist-modulated tumor microenvironment unleashes enzalutamides immunotherapeutic effects
Jianpeng Yu, Xue Jiang, Haipei Yao…·Jiaoti Huang
This study shows that combining enzalutamide with DRP-104 enhances anti-tumor immunity by reducing Treg cells and improving CD8+ T cell activity in prostate cancer.